US starts COVID-19 vaccinations
The US has started COVID-19 vaccinations this morning: after the Pfizer/BioNTech vaccine was granted Emergency Use Authorization (EUA) by the FDA on Friday.
Archives for December 14, 2020
AstraZeneca to acquire Alexion, enhancing presence in immunology
AstraZeneca will acquire Alexion in a deal worth $39bn: supporting its ambition to develop novel medicines in immunology.
Orgenesis signs JV with Korean CGT developer
US headquartered company, Orgenesis, and South Korea-based, Cure Therapeutics, have signed a JV deal to advance the development, regulatory approval, and commercialization of point of care production for both companies’ cell and gene therapies and...
CureVac starts pivotal late stage trial for its mRNA COVID-19 vaccine candidate
CureVac has announced today the enrollment of the first participant in the pivotal Phase 2b/3 study of its messenger ribonucleic acid (mRNA) vaccine candidate, CVnCoV, against COVID-19.